☆ 4.7 Article

gyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-guided Therapy

CLINICAL INFECTIOUS DISEASES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure

Lenka A. Vodstrcil et al.

Summary: This study evaluated the efficacy and tolerability of resistance-guided combination antimicrobial therapy for Mycoplasma genitalium (MG) infection. The combination of doxycycline and azithromycin achieved high cure rates for macrolide-susceptible infections, while the combination of doxycycline and moxifloxacin had a lower cure rate for macrolide-resistant infections. Sequencing revealed that mutations in the parC gene were associated with treatment failure.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Dermatology

2021 European guideline on the management of Mycoplasma genitalium infections

J. S. Jensen et al.

Summary: Mycoplasma genitalium infection is responsible for a significant number of cases of non-chlamydial non-gonococcal urethritis in men and is associated with cervicitis and pelvic inflammatory disease in women. Transmission occurs through direct mucosal contact. Asymptomatic infections are common. Diagnosis is achieved through nucleic acid amplification testing, including investigation for macrolide resistance mutations.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

添加到收藏夹

Article Microbiology

parC Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure

Gerald L. Murray et al.

Summary: Prevalence and trends of parC variants in macrolide-resistant Mycoplasma genitalium were investigated, and the most common variant was found to be 5831. The absence of this variant had a high predictive value for successful moxifloxacin treatment.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Article Infectious Diseases

Individualised treatment of Mycoplasma genitalium infection-incorporation of fluoroquinolone resistance testing into clinical care

Emma L. Sweeney et al.

Summary: Mycoplasma genitalium poses an emerging global health threat with increasing antimicrobial resistance. The use of individualised treatment approaches has been successful for macrolides, but the rise of fluoroquinolone resistance and lack of alternative treatment options complicate treatment. This article discusses the available literature data and highlights issues surrounding individualised treatment using fluoroquinolones, including the hesitance to consider ParC fluoroquinolone resistance mutations in guiding antimicrobial treatments. The authors propose the use of diagnostics that focus on the absence of resistance mutations to inform microbial cure following fluoroquinolone antimicrobials, with Australian data supporting this approach. Development of molecular tests detecting both wild-type and the most common ParC mutation could greatly improve antimicrobial selection, individualise tests of cure, and aid in the care of patients with M genitalium infection.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Microbiology

Molecular Typing Reveals Distinct Mycoplasma genitalium Transmission Networks among a Cohort of Men Who Have Sex with Men and a Cohort of Women in France

Jennifer Guiraud et al.

Summary: This study investigated the genetic relationship between Mycoplasma genitalium strains and their antibiotic resistance profile. The study found that the prevalence of macrolide and fluoroquinolone resistance was significantly higher in MSM than in women. Clonal diffusion of two dual-resistant types was also observed among PrEP users.

MICROORGANISMS (2022)

添加到收藏夹

Article Microbiology

Omadacycline Is Highly Active In Vitro against Mycoplasma genitalium

Ken B. Waites et al.

Summary: In this study, we tested the susceptibility of Mycoplasma genitalium isolates to various antibiotics and found that omadacycline showed the highest potency, even against resistant strains. This suggests that omadacycline could be a potential treatment option for urogenital infections caused by M. genitalium.

MICROBIOLOGY SPECTRUM (2022)

添加到收藏夹

Article Infectious Diseases

Individualised treatment of Mycoplasma genitalium infection-incorporation of fluoroquinolone resistance testing into clinical care

Emma L. Sweeney et al.

Summary: Individualized treatment of Mycoplasma genitalium infection should focus on fluoroquinolone resistance mutations to guide antimicrobial treatment and post-treatment microbial cure. The development of molecular tests that can detect both wild-type sequences and common ParC mutations, such as Ser83Ile, could greatly improve antimicrobial selection and patient care.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Microbiology

Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual- class- resistance markers, in asymptomatic men who have sex with men

Teck-Phui Chua et al.

Summary: This study found that 13% of asymptomatic MSM with Mycoplasma genitalium infections had dual-class resistance mutations. Fluoroquinolone resistance appears to be arising from independent mutation events, and antibiotic resistance is not limited to specific mgp8 sequence types.

JOURNAL OF MEDICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Microbiology

Molecular mechanisms of macrolide and fluoroquinolone resistance among Korean isolates of Mycoplasma genitalium over a period of five years 2014-2019

Yumi Seo et al.

Summary: Antimicrobial resistance in Mycoplasma genitalium varies among different populations in Korea, with higher diversity in isolates with quinolone resistance. The A2059G mutation is significantly associated with mutations at gyrA95, gyrA99, and parC83 sites.

JOURNAL OF MEDICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium isolates from the private healthcare sector in South Africa: A pilot study

L. D. Maduna et al.

Summary: High rates of resistance to ciprofloxacin, penicillin, and tetracycline were observed in N. gonorrhoeae, along with macrolide resistance-associated mutations in M. genitalium in private healthcare sector patients in South Africa. This emphasizes the importance of using diagnostics for sexually transmitted infections and including the private healthcare sector in antimicrobial surveillance and stewardship programs.

SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Retrospective analysis of infection and antimicrobial resistance patterns of Mycoplasma genitalium among pregnant women in the southwestern USA

Irene A. Stafford et al.

Summary: The prevalence rate of Mycoplasma genitalium in pregnant women is 5.7%. It disproportionately affects young black women and is associated with co-infection with Trichomonas vaginalis.

BMJ OPEN (2021)

添加到收藏夹

Letter Microbiology

Genotyping of Mycoplasma genitalium Suggests De Novo Acquisition of Antimicrobial Resistance in Queensland, Australia

Emma L. Sweeney et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

添加到收藏夹

Review Infectious Diseases

Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis

Dorothy A. Machalek et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Biochemical Research Methods

A custom amplicon sequencing approach to detect resistance associated mutations and sequence types in Mycoplasma genitalium

E. L. Plummer et al.

JOURNAL OF MICROBIOLOGICAL METHODS (2020)

添加到收藏夹

Article Immunology

Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation

Tim R. H. Read et al.

CLINICAL INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Infectious Diseases

Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014

Etienne E. Muller et al.

BMC INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Microbiology

gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya

Mary Wandia Kivata et al.

BMC MICROBIOLOGY (2019)

添加到收藏夹

Article Infectious Diseases

Prevalence, Macrolide Resistance, and Fluoroquinolone Resistance in Mycoplasma genitalium in Men Who Have Sex With Men Attending an Sexually Transmitted Disease Clinic in Dublin, Ireland in 2017-2018

Vanessa Mulligan et al.

SEXUALLY TRANSMITTED DISEASES (2019)

添加到收藏夹

Article Microbiology

Molecular Typing of Mycoplasma genitalium-Positive Specimens Discriminates between Persistent and Recurrent Infections in Cases of Treatment Failure and Supports Contact Tracing

Luis Pineiro et al.

MICROORGANISMS (2019)

添加到收藏夹

Article Microbiology

Levels of Mycoplasma genitalium Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines

E. L. Sweeney et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains

Ryoichi Hamasuna et al.

PLOS ONE (2018)

添加到收藏夹

Article Infectious Diseases

Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan

Takashi Deguchi et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2018)

添加到收藏夹

Article Infectious Diseases

Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan

Takashi Deguchi et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2017)

添加到收藏夹

Article Immunology

Mycoplasma genitalium Infection in Men

Patrick J. Horner et al.

JOURNAL OF INFECTIOUS DISEASES (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Mycoplasma genitalium: whole genome sequence analysis, recombination and population structure

Maria C. Fookes et al.

BMC GENOMICS (2017)

添加到收藏夹

Article Immunology

Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium

Gerald L. Murray et al.

EMERGING INFECTIOUS DISEASES (2017)

添加到收藏夹

Letter Immunology

Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France

Chloe Le Roy et al.

EMERGING INFECTIOUS DISEASES (2016)

添加到收藏夹

Review Immunology

Mycoplasma genitalium Infection and Female Reproductive Tract Disease: A Meta-analysis

Rebecca Lis et al.

CLINICAL INFECTIOUS DISEASES (2015)

添加到收藏夹

Article Immunology

Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance

Deborah L. Couldwell et al.

INTERNATIONAL JOURNAL OF STD & AIDS (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

Alexandre Wohlkonig et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)

添加到收藏夹

Article Immunology

Azithromycin Treatment Failure in Mycoplasma genitalium-Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance

Jorgen S. Jensen et al.

CLINICAL INFECTIOUS DISEASES (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.